Vaginal cancer CT

Revision as of 14:03, 6 February 2019 by Syed Musadiq Ali (talk | contribs) (→‎CT Scan)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]

Vaginal cancer Microchapters


Patient Information


Historical Perspective




Differentiating Vaginal cancer from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination


Laboratory Findings

X Ray




Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vaginal cancer CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Vaginal cancer CT

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vaginal cancer CT

CDC on Vaginal cancer CT

Vaginal cancer CT in the news

Blogs on Vaginal cancer CT

Directions to Hospitals Treating Vaginal cancer

Risk calculators and risk factors for Vaginal cancer CT


The computed tomography scan or CAT scan, is an x-ray test that makes detailed cross-sectional images. A CT scan can provide information about the size, shape, and position of a tumor, and can be helpful to see if the cancer has spread to other organs. It can also help find enlarged lymph nodes that might have cancer cells.

CT Scan

Vaginal tumors generally are best seen on T2 imaging, and instilling gel into the vaginal canal, which distends the vaginal walls, often aids in visualizing and assessing the thickness of the vaginal tumor. CT scan can also be helpful for evaluating the primary vaginal tumor and abnormal lymph nodes[1][2][3][4].


  1. Lamoreaux WT, Grigsby PW, Dehdashti F, Zoberi I, Powell MA, Gibb RK, Rader JS, Mutch DG, Siegel BA (July 2005). "FDG-PET evaluation of vaginal carcinoma". Int. J. Radiat. Oncol. Biol. Phys. 62 (3): 733–7. doi:10.1016/j.ijrobp.2004.12.011. PMID 15936553.
  2. Robertson NL, Hricak H, Sonoda Y, Sosa RE, Benz M, Lyons G, Abu-Rustum NR, Sala E, Vargas HA (March 2016). "The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer". Gynecol. Oncol. 140 (3): 420–4. doi:10.1016/j.ygyno.2016.01.011. PMC 4988238. PMID 26790773.
  3. Rajaram S, Maheshwari A, Srivastava A (August 2015). "Staging for vaginal cancer". Best Pract Res Clin Obstet Gynaecol. 29 (6): 822–32. doi:10.1016/j.bpobgyn.2015.01.006. PMID 25847318.
  4. Miccò M, Sala E, Lakhman Y, Hricak H, Vargas HA (December 2015). "Imaging Features of Uncommon Gynecologic Cancers". AJR Am J Roentgenol. 205 (6): 1346–59. doi:10.2214/AJR.14.12695. PMC 5502476. PMID 26587944.